@article{2997238,
    title = "Thrombectomy for Treatment of Acute Stroke in the COVID-19 Pandemic",
    author = "Papanagiotou, P. and Parrilla, G. and Creed Pettigrew, L.",
    journal = "Cerebrovascular Diseases",
    year = "2021",
    volume = "50",
    number = "1",
    pages = "20-25",
    publisher = "S Karger AG",
    issn = "1015-9770, 1421-9786",
    doi = "10.1159/000511729",
    keywords = "ferritin;  fibrinogen;  recombinant plasminogen activator, Article;  blood vessel occlusion;  brain infarction;  brain ischemia;  clinical practice;  computer assisted tomography;  coronavirus disease 2019;  emergency ward;  exposure;  hospitalization;  human;  lymphocytopenia;  mechanical thrombectomy;  National Institutes of Health Stroke Scale;  pandemic;  practice guideline;  recanalization;  screening;  thorax radiography;  thrombectomy;  thrombocytopenia;  adult;  aged;  blood;  blood clotting;  complication;  diagnosis;  etiology;  female;  male;  middle aged;  procedures;  risk factor;  surgery;  thrombectomy;  treatment outcome, Adult;  Aged;  Blood Coagulation;  COVID-19;  Embolic Stroke;  Female;  Humans;  Male;  Middle Aged;  Risk Factors;  Thrombectomy;  Treatment Outcome",
    abstract = "This commentary will focus on the role of thrombectomy for the treatment of embolic stroke during the 2019 novel coronavirus disease (COVID-19). We will begin with review of recently promulgated guidelines for use of thrombectomy in COVID-19-associated stroke. We will then survey the reported experience of thrombectomy applied to treatment of large-vessel occlusion (LVO) stroke in COVID-19. We will conclude by discussing unusual challenges confronted by neuro-interventionalists seeking to perform thrombectomy in COVID-19 patients with acute LVO stroke. © 2020 S. Karger AG, Basel. Copyright: All rights reserved."
}